stars 1 stars 2 stars 3

METABOLIUM’s main purpose is to prevent metabolic disorders caused by aging and poor diet, and to increase individuals'​ resistance to contamination resulting from excessive concentrations in urban areas or in aquaculture cages. To challenge these issues, the Company has developed the patented ALGOSELEN process that enrich microalgae with organic selenium (almost exclusively as L(+) selenomethionine) from an original molecule. This molecule is incorporated into proteins in the same way that selenium is assimilated naturally by plants, and supports the same vital functions. The products uniquely combine selenium's antioxidant properties and the exceptional benefits of microalgae. METABOLIUM is actively looking for partners in the United States, Europe and Asia who can produce under license and sell locally. The company now offers products in the fields of human and animal nutrition, including aquaculture, and is developing new innovative personal and health care products.

Metabolium Questions

The Metabolium annual revenue was $3 million in 2026.

Metabolium is based in Romainville, Ile-de-France.

The NAICS codes for Metabolium are [32, 325, 32541, 3254].

The SIC codes for Metabolium are [28, 283].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users